Gilad Goldhirsh
3PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Dec 17, 2024
CXCL12 restricts tumor growth by suppressing the Ras, ERK1/2, c-Myc, and the immune checkpoint PD-L1 pathways.Yelena Kravtsova-Ivantsiv, Gilad Goldhirsh, Aaron Ciechanover
|Dec 07, 2021
A short binding site in the KPC1 ubiquitin ligase mediates processing of NF-κB1 p105 to p50: A potential for a tumor-suppressive PROTAC.Gilad Goldhirsh, Yelena Kravtsova-Ivantsiv, Gandhesiri Satish
|Nov 10, 2020
Excess of the NF-ĸB p50 subunit generated by the ubiquitin ligase KPC1 suppresses tumors via PD-L1- and chemokines-mediated mechanisms.Yelena Kravtsova-Ivantsiv, Gilad Goldhirsh, Alexandra Ivantsiv
Pageof 1
